Artivion (AORT) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66.94% |
| Dec 31, 2025 | -67.04% |
| Sep 30, 2025 | 41.33% |
| Jun 30, 2025 | -15.81% |
| Mar 31, 2025 | -4.62% |
| Dec 31, 2024 | -29.07% |
| Sep 30, 2024 | 9.06% |
| Jun 30, 2024 | -2.52% |
| Mar 31, 2024 | -20.40% |
| Dec 31, 2023 | -9.21% |
| Sep 30, 2023 | -8.65% |
| Jun 30, 2023 | 46.21% |
| Mar 31, 2023 | -6.05% |
| Dec 31, 2022 | 56.24% |
| Sep 30, 2022 | -21.52% |
| Jun 30, 2022 | -0.46% |
| Mar 31, 2022 | -15.37% |
| Dec 31, 2021 | 18.46% |
| Sep 30, 2021 | 58.42% |
| Jun 30, 2021 | -25.45% |
| Mar 31, 2021 | 58.67% |
| Dec 31, 2020 | -6.87% |
| Sep 30, 2020 | -130.68% |
| Jun 30, 2020 | -45.98% |
| Mar 31, 2020 | -13.37% |
| Dec 31, 2019 | -42.34% |
| Sep 30, 2019 | -76.00% |
| Jun 30, 2019 | -0.96% |
| Mar 31, 2019 | 3.20% |
| Dec 31, 2018 | -16.22% |
| Sep 30, 2018 | -5.85% |
| Jun 30, 2018 | -3.07% |
| Mar 31, 2018 | -14.60% |
| Dec 31, 2017 | -144.34% |
| Sep 30, 2017 | 7.31% |
| Jun 30, 2017 | 34.50% |
| Mar 31, 2017 | -10.92% |
| Dec 31, 2016 | -67.82% |
| Sep 30, 2016 | 16.44% |
| Jun 30, 2016 | 38.09% |
| Mar 31, 2016 | -196.11% |
| Dec 31, 2015 | -16.24% |
| Sep 30, 2015 | 30.41% |